Table of Contents










These African heiresses are either giving back to the community or helping to grow their parents’ businesses.
IHS rebounds with $439.6 million in Q1 2025 revenue, driven by 25.6% organic growth and improved margins despite naira headwinds and prior regional divestments.
This mirrors wider investor caution amid challenges facing the global pharmaceutical sector and instability in emerging markets.
The sale was part of automatic transactions to cover tax obligations related to vested restricted stock units.
OCI nears completion of Beaumont ammonia plant and plans $1 billion shareholder payout as part of a wider transformation under billionaire Nassef Sawiris.